At JY BioMed, we are advancing a diversified pipeline of investigational programs targeting oncology, regenerative health, and immune modulation. Our focus is on building platforms that are scalable, scientifically rigorous, and globally compliant. Each program is carefully designed to address significant areas of unmet medical need through innovative approaches in cell therapy, exosome therapeutics, and targeted biologics. Our pipeline spans from discovery through early clinical development, with a strong commitment to regulatory excellence and scientific validation.